Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-04-24 | Timothy M. Shannon, M.D. became a director of Celldex in October 2009 upon the acquisition of CuraGen Corporation. In December 2011, the Board of Directors established a Scientific Advisory Committee consisting initially of Dr. Timothy Shannon, Chairman. The following table summarizes the annual compensation for our non-employee directors during 2011. Timothy M. Shannon, M.D. Fees Earned or Paid in Cash $51,250 Stock Awards $6,480 Total $57,730 |
| 2013-04-23 | Timothy M. Shannon, M.D. became a director of Celldex in October 2009 upon the acquisition of CuraGen Corporation ("CuraGen") by Celldex (the "CuraGen Acquisition"). The Board of Directors has established a Scientific Advisory Committee consisting of Dr. Timothy Shannon, Chair. The following table summarizes the annual compensation for our non-employee directors during 2012. Timothy M. Shannon, M.D. Fees Earned or Paid in Cash $80,000 Stock Awards $9,000 Total $89,000 |
| 2014-04-09 | Timothy M. Shannon, M.D. 55 2009 The Board of Directors has established a Scientific Advisory Committee consisting of Dr. Timothy Shannon, Chair. The following table summarizes the annual compensation for our non-employee directors during 2013. Timothy M. Shannon, M.D. 80,000 30,400 19,481 129,881 |
Data sourced from SEC filings. Last updated: 2025-10-12